APA (7th ed.) Citation

Liu, N., Wei, W., Ren, K., Liang, D., Yang, D., Zhang, W., . . . Zhao, X. (2025). Ephrin A1 ligand‐based CAR‐T cells for immunotherapy of EphA2‐positive cancer. Medcomm: Oncology, 4(1), 1. https://doi.org/10.1002/mog2.70010

Chicago Style (17th ed.) Citation

Liu, Nan, et al. "Ephrin A1 Ligand‐based CAR‐T Cells for Immunotherapy of EphA2‐positive Cancer." Medcomm: Oncology 4, no. 1 (2025): 1. https://doi.org/10.1002/mog2.70010.

MLA (9th ed.) Citation

Liu, Nan, et al. "Ephrin A1 Ligand‐based CAR‐T Cells for Immunotherapy of EphA2‐positive Cancer." Medcomm: Oncology, vol. 4, no. 1, 2025, p. 1, https://doi.org/10.1002/mog2.70010.